| Mar'20 | Sep'19 | Mar'19 | Sep'18 | |||
|---|---|---|---|---|---|---|
Revenue | ||||||
2,021 | 2,265 | 2,094 | 2,445 | |||
Cost of revenue | ||||||
1,024 | 1,079 | 1,022 | 1,189 | |||
Gross profit | ||||||
997 | 1,186 | 1,072 | 1,256 | |||
Research and development | ||||||
425 | 396 | 415 | 433 | |||
Selling, general and administrative | ||||||
233 | 221 | 248 | 252 | |||
Amortization of acquisition-related intangible assets | ||||||
381 | 358 | 357 | 362 | |||
Total operating expenses | ||||||
1,039 | 975 | 1,020 | 1,047 | |||
Other income (expense) | ||||||
110 | 22 | 2 | 2,002 | |||
Operating income (loss) | ||||||
68 | 233 | 54 | 2,211 | |||
Financial income (expense): | ||||||
Gain (Loss) on Extinguishment of Debt | ||||||
- | -1 | - | 0 | |||
Other financial income (expense) | ||||||
-78 | -84 | -83 | -119 | |||
Income (loss) before income taxes | ||||||
-10 | 148 | -29 | 2,092 | |||
Benefit (provision) for income taxes | ||||||
2 | 28 | -9 | 311 | |||
Results relating to equity-accounted investees | ||||||
-1 | -1 | 4 | 52 | |||
Net income (loss) | ||||||
-13 | 119 | -16 | 1,833 | |||
Less: Net income (loss) attributable to non-controlling interests | ||||||
8 | 10 | 5 | 13 | |||
Net income (loss) attributable to stockholders | ||||||
-21 | 109 | -21 | 1,820 | |||
Earnings per share data: | ||||||
Basic earnings per common share attributable to stockholders in $ | ||||||
Basic (in dollars per share) | ||||||
-0.08 | 0.39 | -0.07 | 5.64 | |||
Diluted earnings per common share attributable to stockholders in $ | ||||||
Diluted (in dollars per share) | ||||||
-0.08 | 0.38 | -0.07 | 5.60 | |||
Weighted average number of shares of common stock outstanding during the period (in thousands): | ||||||
Basic (in shares) | ||||||
279 | 279 | 287 | 322 | |||
Diluted (in shares) | ||||||
279 | 283 | 287 | 325 | |||
Net income (loss) | ||||||
-13 | 119 | -16 | 1,833 | |||